Importance Intracranial metastatic disease (IMD) is a severe complication of cancer with
profound prognostic implications. Patients with IMD in the setting of limited or stable extracranial …

Aims Individuals with type 1 diabetes (T1D) are at an increased risk of chronic kidney disease
making estimation of glomerular filtration rate (eGFR) an important component of diabetes …

Background Patients with small-cell lung cancer (SCLC) are at high risk for intracranial
metastatic disease (IMD). Although stereotactic radiosurgery (SRS) has supplanted whole brain …

Purpose The incidence of intracranial metastatic disease (IMD) in patients with gastrointestinal
(GI) cancers is rising. Expression of the erythroblastic oncogene B-2 (ERBB2) is …

Intracranial metastatic disease (IMD) is a prevalent complication of cancer that significantly
limits patient survival and quality of life. Over the past half-century, our understanding of the …

Simple Summary The development of brain metastases, or intracranial metastatic disease (IMD),
is a serious and life-altering complication for many patients with cancer. While there …

Background Patients with small cell lung cancer (SCLC) are at high risk for brain metastases.
Prophylactic cranial irradiation (PCI) is recommended in this population to reduce the …

Importance Wearing a face mask in school can reduce SARS-CoV-2 transmission but it may
also lead to increased hand-to-face contact, which in turn could increase infection risk …

Intracranial metastatic disease (IMD) is a common complication for patients with small cell
lung cancer (SCLC). As many as 40-60% of patients with SCLC will develop brain metastases …

METHODS: We included all patients diagnosed with SCLC between April 2007 and March
2018 identified through a provincial health administrative database. Information on patient …